Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.

Chaillon A, Wynn A, Kushner T, Reau N, Martin NK. Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States. Clin Infect Dis. 2021 11 02; 73(9):e3355-e3357.

View in: PubMed

subject areas

Cost-Benefit Analysis
Female
Hepacivirus
Hepatitis C
Humans
Mass Screening
Pregnancy
Pregnant Women
Quality-Adjusted Life Years
United States

authors with profiles

Nancy Reau